Tag: chris-nash
-
UK urged to stop locking up stateless "ghost people"
By Emma Batha LONDON (Thomson Reuters Foundation) – Britain is locking up stateless people for long periods even though there is nowhere they can be deported to, campaigners, lawyers and academics said on Thursday as they called for a strict time limit on detention. The European Network on Statelessness (ENS) estimates several hundred stateless people…
-
UK urged to stop locking up stateless "ghost people"
By Emma Batha LONDON (Thomson Reuters Foundation) – Britain is locking up stateless people for long periods even though there is nowhere they can be deported to, campaigners, lawyers and academics said on Thursday as they called for a strict time limit on detention. The European Network on Statelessness (ENS) estimates several hundred stateless people…
-
India’s move to curb "black money" will break backbone of traffickers: Satyarthi
By Nita Bhalla NEW DELHI (Thomson Reuters Foundation) – Nobel laureate Kailash Satyarthi has welcomed India’s overnight move to withdraw 500 and 1,000 rupee notes from circulation to crack down on corruption and counterfeit currency, saying it would also to help curb human trafficking and child slavery. The shock currency move, announced late on Tuesday…
-
Novartis, Pfizer cut prices to win UK approval for cancer drugs
Novartis and Pfizer have won approval for two cancer drugs to be used routinely on Britain’s National Health Service after offering bigger price discounts. The National Institute for Health and Care Excellence (NICE) said on Thursday its draft guidance now recommended Novartis’ Afinitor for certain breast cancer patients and Pfizer’s Xalkori in lung cancer following…
-
Exclusive: Pfizer weighs sale or spin-off of consumer health unit – sources
By Lauren Hirsch, Olivia Oran and Carl O'Donnell (Reuters) – U.S. drugmaker Pfizer Inc is evaluating a potential sale or spin-off of its consumer health division that could value the unit at as much as $14 billion, people familiar with the matter said on Wednesday. A Pfizer exit from the consumer health business, which includes…